Annual report pursuant to Section 13 and 15(d)

Earnings per Common Share (Details)

v3.8.0.1
Earnings per Common Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jul. 01, 2017
Apr. 01, 2017
Dec. 31, 2016
Oct. 01, 2016
Jul. 02, 2016
Apr. 02, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Earnings Per Share [Abstract]                      
Net Earnings from Continuing Operations $ (90.4) [1] $ 84.7 [1] $ 118.8 [1] $ 74.2 [1] $ 16.7 $ 84.1 $ 108.4 $ 63.4 $ 187.3 [1] $ 272.6 $ 230.9
Net Earnings (Loss) from Discontinued Operations, Net of Tax (26.5) (5.7) 0.6 (9.3) 1.0 1.3 (0.3) 1.4 (40.9) 3.4 10.5
Net Earnings $ (116.9) $ 79.0 $ 119.4 $ 64.9 $ 17.7 $ 85.4 $ 108.1 $ 64.8 $ 146.4 $ 276.0 $ 241.4
Weighted Average Outstanding Shares - Basic (in Shares)                 89.4 91.2 93.0
Dilutive Effect of Common Stock Equivalents (in Shares)                 0.7 0.8 1.3
Weighted Average Outstanding Shares - Diluted (in Shares)                 90.1 92.0 94.3
Basic Earnings Per Common Share                      
Continuing Operations (in Dollars Per Share) $ (1.02) $ 0.95 $ 1.32 $ 0.82 $ 0.19 $ 0.93 $ 1.18 $ 0.69 $ 2.10 $ 2.99 $ 2.49
Discontinued Operations (in Dollars Per Share) (0.30) (0.06) 0.01 (0.10) 0.01 0.01 0.00 0.02 (0.46) 0.04 0.11
Net Earnings (in Dollars per Share) (1.32) 0.89 1.33 0.72 0.20 0.94 1.18 0.71 1.64 3.03 2.60
Diluted Earnings Per Common Share                      
Continuing Operations (in Dollars per Share) (1.02) 0.94 1.31 0.81 0.18 0.92 1.17 0.68 2.08 2.96 2.45
Discontinued Operations (in Dollars per Share) (0.30) (0.06) 0.01 (0.10) 0.01 0.01 0.00 0.02 (0.46) 0.04 0.11
Net Earnings (in Dollars per Share) $ (1.32) $ 0.88 $ 1.32 $ 0.71 $ 0.19 $ 0.93 $ 1.17 $ 0.70 $ 1.62 $ 3.00 $ 2.56
[1] (D) In the fourth quarter of 2017, Gross margin and Net earnings from continuing operations include $8.4 million and $13.5 million, respectively, of charges for costs related to field campaigns pertaining to certain Cybex products designed prior to the acquisition. Refer to Note 13 – Commitments and Contingencies for further details.